Analyst Expectations For Celldex Therapeutics's Future
Analyst Expectations For Celldex Therapeutics's Future
塞德斯医疗未来的分析师期望
In the preceding three months, 5 analysts have released ratings for Celldex Therapeutics (NASDAQ:CLDX), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中,有5位分析师公布了Celldex Therapeutics(纳斯达克股票代码:CLDX)的评级,提出了从看涨到看跌的各种观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级,阐明了过去30天内情绪的变化,并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $77.4, a high estimate of $80.00, and a low estimate of $67.00. This current average has not changed from the previous average price target.
分析师12个月目标股价的见解已经公布,平均目标股价为77.4美元,最高估计为80.00美元,低估值为67.00美元。当前的平均价格与之前的平均目标价格相比没有变化。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级:一项详尽的研究
A comprehensive examination of how financial experts perceive Celldex Therapeutics is derived...
对金融专家如何看待Cel...
登录免费看全文
登录/注册